

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.64371553 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.51220144 |
| 3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.51220144 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.41227646 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.41227646 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.25402682 |
| 7 | negative thymic T cell selection (GO:0045060) | 4.06521675 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.03731128 |
| 9 | negative T cell selection (GO:0043383) | 4.03232456 |
| 10 | DNA unwinding involved in DNA replication (GO:0006268) | 3.96055380 |
| 11 | regulation of gamma-delta T cell activation (GO:0046643) | 3.90140729 |
| 12 | positive thymic T cell selection (GO:0045059) | 3.86633700 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.86167086 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.86167086 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 3.86167086 |
| 16 | positive regulation by symbiont of host defense response (GO:0052509) | 3.86167086 |
| 17 | modulation by symbiont of host defense response (GO:0052031) | 3.86167086 |
| 18 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.86167086 |
| 19 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.79611158 |
| 20 | protein localization to kinetochore (GO:0034501) | 3.72371678 |
| 21 | negative regulation of histone methylation (GO:0031061) | 3.70621869 |
| 22 | detection of other organism (GO:0098543) | 3.70284344 |
| 23 | response to peptidoglycan (GO:0032494) | 3.69649363 |
| 24 | activation of MAPKKK activity (GO:0000185) | 3.68464055 |
| 25 | germinal center formation (GO:0002467) | 3.65047849 |
| 26 | detection of bacterium (GO:0016045) | 3.63828506 |
| 27 | thymic T cell selection (GO:0045061) | 3.52885882 |
| 28 | NIK/NF-kappaB signaling (GO:0038061) | 3.52470836 |
| 29 | dosage compensation (GO:0007549) | 3.51017142 |
| 30 | response to type I interferon (GO:0034340) | 3.46330904 |
| 31 | type I interferon signaling pathway (GO:0060337) | 3.46037248 |
| 32 | cellular response to type I interferon (GO:0071357) | 3.46037248 |
| 33 | pre-miRNA processing (GO:0031054) | 3.45815142 |
| 34 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.34493203 |
| 35 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.33988324 |
| 36 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.29906311 |
| 37 | histone H3-K36 demethylation (GO:0070544) | 3.28751371 |
| 38 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.27033911 |
| 39 | cellular response to virus (GO:0098586) | 3.25712606 |
| 40 | nuclear pore complex assembly (GO:0051292) | 3.24702437 |
| 41 | mitotic nuclear envelope disassembly (GO:0007077) | 3.22006589 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.20683675 |
| 43 | protein localization to chromosome, centromeric region (GO:0071459) | 3.19955781 |
| 44 | positive regulation of histone deacetylation (GO:0031065) | 3.16350865 |
| 45 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 3.14741731 |
| 46 | T cell selection (GO:0045058) | 3.14388219 |
| 47 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.13290773 |
| 48 | positive T cell selection (GO:0043368) | 3.13136703 |
| 49 | mitotic chromosome condensation (GO:0007076) | 3.10115492 |
| 50 | nuclear pore organization (GO:0006999) | 3.08578368 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.07031780 |
| 52 | membrane disassembly (GO:0030397) | 3.03593731 |
| 53 | nuclear envelope disassembly (GO:0051081) | 3.03593731 |
| 54 | peptidyl-lysine dimethylation (GO:0018027) | 3.03283464 |
| 55 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.02955988 |
| 56 | response to laminar fluid shear stress (GO:0034616) | 3.02692254 |
| 57 | translesion synthesis (GO:0019985) | 3.02623215 |
| 58 | DNA duplex unwinding (GO:0032508) | 3.02200962 |
| 59 | regulation of translational fidelity (GO:0006450) | 3.01976374 |
| 60 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.01348322 |
| 61 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.00445390 |
| 62 | mannose metabolic process (GO:0006013) | 2.98794452 |
| 63 | DNA geometric change (GO:0032392) | 2.97039504 |
| 64 | detection of external biotic stimulus (GO:0098581) | 2.95986708 |
| 65 | negative regulation of RNA splicing (GO:0033119) | 2.95714716 |
| 66 | natural killer cell differentiation (GO:0001779) | 2.93965128 |
| 67 | negative regulation of interleukin-12 production (GO:0032695) | 2.93186056 |
| 68 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.92192259 |
| 69 | RNA stabilization (GO:0043489) | 2.89785260 |
| 70 | mRNA stabilization (GO:0048255) | 2.89785260 |
| 71 | embryonic process involved in female pregnancy (GO:0060136) | 2.88665689 |
| 72 | regulation of histone H3-K9 methylation (GO:0051570) | 2.86601085 |
| 73 | mitotic sister chromatid cohesion (GO:0007064) | 2.85779948 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.83256969 |
| 75 | corticosteroid receptor signaling pathway (GO:0031958) | 2.81890616 |
| 76 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80940147 |
| 77 | response to host immune response (GO:0052572) | 2.80940147 |
| 78 | nucleosome disassembly (GO:0006337) | 2.80695258 |
| 79 | protein-DNA complex disassembly (GO:0032986) | 2.80695258 |
| 80 | regulation of chromatin binding (GO:0035561) | 2.80263999 |
| 81 | detection of biotic stimulus (GO:0009595) | 2.79573275 |
| 82 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.78436220 |
| 83 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78177812 |
| 84 | tolerance induction (GO:0002507) | 2.77655266 |
| 85 | B cell receptor signaling pathway (GO:0050853) | 2.77477929 |
| 86 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.76100691 |
| 87 | modulation by symbiont of host cellular process (GO:0044068) | 2.74024891 |
| 88 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73049816 |
| 89 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.72433937 |
| 90 | DNA strand elongation (GO:0022616) | 2.72347630 |
| 91 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.72182479 |
| 92 | response to host (GO:0075136) | 2.71185060 |
| 93 | response to host defenses (GO:0052200) | 2.71185060 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71185060 |
| 95 | histone H2A monoubiquitination (GO:0035518) | 2.69153174 |
| 96 | heterochromatin organization (GO:0070828) | 2.68669064 |
| 97 | detection of molecule of bacterial origin (GO:0032490) | 2.66366553 |
| 98 | regulation of translational termination (GO:0006449) | 2.65481189 |
| 99 | NLS-bearing protein import into nucleus (GO:0006607) | 2.65012125 |
| 100 | cellular extravasation (GO:0045123) | 2.64477015 |
| 101 | T cell apoptotic process (GO:0070231) | 2.63676382 |
| 102 | regulation of necroptotic process (GO:0060544) | 2.63257718 |
| 103 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62969049 |
| 104 | sister chromatid segregation (GO:0000819) | 2.62912521 |
| 105 | positive regulation of interferon-alpha production (GO:0032727) | 2.62662013 |
| 106 | histone lysine demethylation (GO:0070076) | 2.62214458 |
| 107 | regulation of interferon-alpha production (GO:0032647) | 2.60677962 |
| 108 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.60236009 |
| 109 | response to muramyl dipeptide (GO:0032495) | 2.60219848 |
| 110 | modulation by virus of host process (GO:0019054) | 2.60042823 |
| 111 | protein localization to endosome (GO:0036010) | 2.59638713 |
| 112 | positive regulation of protein deacetylation (GO:0090312) | 2.59482133 |
| 113 | response to interleukin-15 (GO:0070672) | 2.59202018 |
| 114 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.58994128 |
| 115 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.58418764 |
| 116 | histone demethylation (GO:0016577) | 2.57985769 |
| 117 | positive regulation of type 2 immune response (GO:0002830) | 2.57442030 |
| 118 | barbed-end actin filament capping (GO:0051016) | 2.56553285 |
| 119 | negative regulation of myotube differentiation (GO:0010832) | 2.54396188 |
| 120 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.53865876 |
| 121 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.53252233 |
| 122 | nuclear envelope organization (GO:0006998) | 2.52999440 |
| 123 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.51742491 |
| 124 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51730921 |
| 125 | negative regulation of T cell mediated immunity (GO:0002710) | 2.51645650 |
| 126 | chromatin assembly (GO:0031497) | 2.51589181 |
| 127 | negative regulation of mRNA metabolic process (GO:1903312) | 2.51503163 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.51353938 |
| 129 | epithelial cell fate commitment (GO:0072148) | 2.51238919 |
| 130 | regulation of T cell tolerance induction (GO:0002664) | 2.50257876 |
| 131 | DNA replication initiation (GO:0006270) | 2.49879193 |
| 132 | negative regulation of mRNA processing (GO:0050686) | 2.48580622 |
| 133 | positive regulation of B cell differentiation (GO:0045579) | 2.47902115 |
| 134 | positive regulation of isotype switching (GO:0045830) | 2.44253659 |
| 135 | immunoglobulin mediated immune response (GO:0016064) | 2.43674636 |
| 136 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42380509 |
| 137 | positive regulation of RNA splicing (GO:0033120) | 2.41881954 |
| 138 | alternative mRNA splicing, via spliceosome (GO:0000380) | 2.41078518 |
| 139 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.41074470 |
| 140 | mitotic sister chromatid segregation (GO:0000070) | 2.40558319 |
| 141 | regulation of erythrocyte differentiation (GO:0045646) | 2.40032437 |
| 142 | regulation of protein heterodimerization activity (GO:0043497) | 2.39976942 |
| 143 | negative regulation of innate immune response (GO:0045824) | 2.39759892 |
| 144 | negative regulation of viral release from host cell (GO:1902187) | 2.39600203 |
| 145 | positive regulation of Rap GTPase activity (GO:0032854) | 2.39563434 |
| 146 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.38919608 |
| 147 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.38919608 |
| 148 | apoptotic process involved in morphogenesis (GO:0060561) | 2.37700294 |
| 149 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.37438344 |
| 150 | B cell homeostasis (GO:0001782) | 2.37140612 |
| 151 | negative regulation of cell size (GO:0045792) | 2.37089552 |
| 152 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.36033844 |
| 153 | pore complex assembly (GO:0046931) | 2.35447969 |
| 154 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.35390409 |
| 155 | interferon-gamma production (GO:0032609) | 2.35154559 |
| 156 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.34940898 |
| 157 | T cell migration (GO:0072678) | 2.34528767 |
| 158 | erythrocyte maturation (GO:0043249) | 2.34518843 |
| 159 | gene silencing (GO:0016458) | 2.34496311 |
| 160 | positive regulation of lamellipodium assembly (GO:0010592) | 2.33863038 |
| 161 | IMP biosynthetic process (GO:0006188) | 2.33375826 |
| 162 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.32229349 |
| 163 | histone H3-K4 methylation (GO:0051568) | 2.31735971 |
| 164 | defense response to protozoan (GO:0042832) | 2.30973789 |
| 165 | leukocyte aggregation (GO:0070486) | 2.30286274 |
| 166 | regulation of B cell differentiation (GO:0045577) | 2.30245044 |
| 167 | DNA conformation change (GO:0071103) | 2.29833700 |
| 168 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.29242401 |
| 169 | regulation of leukocyte degranulation (GO:0043300) | 2.27553780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.40610090 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.30019541 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 4.07536151 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.94654434 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.96367867 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.92112855 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.90900328 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54037379 |
| 9 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.47264595 |
| 10 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.30110247 |
| 11 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.21548972 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16323000 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.15270000 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.09747335 |
| 15 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.03649056 |
| 16 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.00191004 |
| 17 | KDM2B_26808549_Chip-Seq_K562_Human | 1.97947134 |
| 18 | * CIITA_25753668_ChIP-Seq_RAJI_Human | 1.95795327 |
| 19 | UTX_26944678_Chip-Seq_JUKART_Human | 1.95310848 |
| 20 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.92401921 |
| 21 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.83977266 |
| 22 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82703932 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82473697 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.82102816 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.81980174 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.80513835 |
| 27 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.80144509 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.79389899 |
| 29 | MYB_26560356_Chip-Seq_TH2_Human | 1.71171920 |
| 30 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.71134871 |
| 31 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.70459278 |
| 32 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.69646152 |
| 33 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.66169229 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62833752 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62579394 |
| 36 | MYB_26560356_Chip-Seq_TH1_Human | 1.59128817 |
| 37 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.59113904 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.58557065 |
| 39 | GATA1_19941826_ChIP-Seq_K562_Human | 1.56984075 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.56397418 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.56106394 |
| 42 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.55372745 |
| 43 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53991461 |
| 44 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53411395 |
| 45 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.50223099 |
| 46 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.49529515 |
| 47 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.49176784 |
| 48 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.46556072 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.45470375 |
| 50 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43499756 |
| 51 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42787503 |
| 52 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.42319525 |
| 53 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.41196015 |
| 54 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.40956264 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.39508443 |
| 56 | MAF_26560356_Chip-Seq_TH2_Human | 1.38725780 |
| 57 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.36980582 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.32349203 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31675043 |
| 60 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.30543446 |
| 61 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30172146 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28808369 |
| 63 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26753318 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26739525 |
| 65 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.26376780 |
| 66 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.23788528 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.22183330 |
| 68 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22080173 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21870347 |
| 70 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.21783764 |
| 71 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.21561493 |
| 72 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.21179405 |
| 73 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20893506 |
| 74 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.20112183 |
| 75 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19847286 |
| 76 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19762113 |
| 77 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.18992763 |
| 78 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18719308 |
| 79 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.18324631 |
| 80 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.17372158 |
| 81 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17192018 |
| 82 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16129743 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15824895 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14866322 |
| 85 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.13009657 |
| 86 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.12918608 |
| 87 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12740234 |
| 88 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12637049 |
| 89 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11827832 |
| 90 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.11139619 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11121278 |
| 92 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09876787 |
| 93 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09784228 |
| 94 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08020072 |
| 95 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07503651 |
| 96 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.07158799 |
| 97 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06934163 |
| 98 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06652238 |
| 99 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.06461066 |
| 100 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06278417 |
| 101 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.04486766 |
| 102 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.04084850 |
| 103 | P68_20966046_ChIP-Seq_HELA_Human | 1.03371752 |
| 104 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03082313 |
| 105 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.01352679 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01053759 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.00127632 |
| 108 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99340675 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98958112 |
| 110 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98455462 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.98093350 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98060947 |
| 113 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97141897 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96919402 |
| 115 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96787492 |
| 116 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.96467783 |
| 117 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.96223176 |
| 118 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.96122330 |
| 119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.95609482 |
| 120 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95164342 |
| 121 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95122010 |
| 122 | GATA2_19941826_ChIP-Seq_K562_Human | 0.95032759 |
| 123 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.94921471 |
| 124 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.94143659 |
| 125 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.93963639 |
| 126 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.93919484 |
| 127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.93087672 |
| 128 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.93063140 |
| 129 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.92822359 |
| 130 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92554856 |
| 131 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92506681 |
| 132 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92384858 |
| 133 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92005473 |
| 134 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.91872252 |
| 135 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.91574518 |
| 136 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91160303 |
| 137 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.91141628 |
| 138 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90220802 |
| 139 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90018095 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005076_abnormal_cell_differentiation | 2.84871163 |
| 2 | MP0000685_abnormal_immune_system | 2.83700354 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.80903903 |
| 4 | MP0003111_abnormal_nucleus_morphology | 2.74992528 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.73429868 |
| 6 | MP0003724_increased_susceptibility_to | 2.69318664 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.65763776 |
| 8 | MP0005451_abnormal_body_composition | 2.62722914 |
| 9 | MP0003077_abnormal_cell_cycle | 2.35686254 |
| 10 | MP0004858_abnormal_nervous_system | 2.34892120 |
| 11 | MP0008260_abnormal_autophagy | 2.31037189 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.30231412 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.29146705 |
| 14 | MP0004808_abnormal_hematopoietic_stem | 2.27962799 |
| 15 | MP0009278_abnormal_bone_marrow | 2.24608907 |
| 16 | MP0002398_abnormal_bone_marrow | 2.22717318 |
| 17 | MP0003693_abnormal_embryo_hatching | 2.20798018 |
| 18 | MP0010307_abnormal_tumor_latency | 2.17045862 |
| 19 | MP0000703_abnormal_thymus_morphology | 2.05648908 |
| 20 | MP0003303_peritoneal_inflammation | 2.05053416 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.03799526 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.01801222 |
| 23 | MP0005397_hematopoietic_system_phenotyp | 2.01801222 |
| 24 | MP0001800_abnormal_humoral_immune | 1.98341992 |
| 25 | MP0008057_abnormal_DNA_replication | 1.96470403 |
| 26 | MP0002009_preneoplasia | 1.96412579 |
| 27 | MP0003436_decreased_susceptibility_to | 1.86946226 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.86833921 |
| 29 | MP0008961_abnormal_basal_metabolism | 1.83331488 |
| 30 | MP0000350_abnormal_cell_proliferation | 1.80888601 |
| 31 | MP0002722_abnormal_immune_system | 1.78515096 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.77694595 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.77303543 |
| 34 | MP0001873_stomach_inflammation | 1.72896102 |
| 35 | MP0001819_abnormal_immune_cell | 1.71418509 |
| 36 | MP0002420_abnormal_adaptive_immunity | 1.71308882 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.68681345 |
| 38 | MP0005671_abnormal_response_to | 1.68656233 |
| 39 | MP0000716_abnormal_immune_system | 1.68204051 |
| 40 | MP0001730_embryonic_growth_arrest | 1.66519124 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.65350465 |
| 42 | MP0001790_abnormal_immune_system | 1.64984860 |
| 43 | MP0005387_immune_system_phenotype | 1.64984860 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.62192966 |
| 45 | MP0002429_abnormal_blood_cell | 1.59029164 |
| 46 | MP0006082_CNS_inflammation | 1.57530891 |
| 47 | MP0002723_abnormal_immune_serum | 1.57314446 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.56299297 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.55642151 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.53300027 |
| 51 | MP0002405_respiratory_system_inflammati | 1.52111638 |
| 52 | MP0002254_reproductive_system_inflammat | 1.51506352 |
| 53 | MP0008007_abnormal_cellular_replicative | 1.49073127 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.48895546 |
| 55 | MP0004947_skin_inflammation | 1.44786448 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.44784346 |
| 57 | MP0004510_myositis | 1.44140597 |
| 58 | MP0000490_abnormal_crypts_of | 1.39956144 |
| 59 | MP0005058_abnormal_lysosome_morphology | 1.38933101 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.37672410 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.32415998 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.29836199 |
| 63 | MP0009840_abnormal_foam_cell | 1.28573361 |
| 64 | MP0003984_embryonic_growth_retardation | 1.27392721 |
| 65 | MP0002998_abnormal_bone_remodeling | 1.26870405 |
| 66 | MP0000858_altered_metastatic_potential | 1.26832277 |
| 67 | MP0002088_abnormal_embryonic_growth/wei | 1.24714761 |
| 68 | MP0002138_abnormal_hepatobiliary_system | 1.24335901 |
| 69 | MP0002006_tumorigenesis | 1.23740561 |
| 70 | MP0002089_abnormal_postnatal_growth/wei | 1.22704375 |
| 71 | MP0000313_abnormal_cell_death | 1.22543078 |
| 72 | MP0005025_abnormal_response_to | 1.21907748 |
| 73 | MP0001348_abnormal_lacrimal_gland | 1.20876407 |
| 74 | MP0001697_abnormal_embryo_size | 1.19206852 |
| 75 | MP0005380_embryogenesis_phenotype | 1.18315578 |
| 76 | MP0001672_abnormal_embryogenesis/_devel | 1.18315578 |
| 77 | MP0003566_abnormal_cell_adhesion | 1.17682840 |
| 78 | MP0002080_prenatal_lethality | 1.17244269 |
| 79 | MP0005310_abnormal_salivary_gland | 1.17115425 |
| 80 | MP0002086_abnormal_extraembryonic_tissu | 1.16713549 |
| 81 | MP0005464_abnormal_platelet_physiology | 1.16211569 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 1.15716122 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.14679781 |
| 84 | MP0008058_abnormal_DNA_repair | 1.12095201 |
| 85 | MP0003045_fibrosis | 1.10581183 |
| 86 | MP0001851_eye_inflammation | 1.09787766 |
| 87 | MP0003172_abnormal_lysosome_physiology | 1.08065669 |
| 88 | MP0003866_abnormal_defecation | 1.07975050 |
| 89 | MP0003828_pulmonary_edema | 1.07338685 |
| 90 | MP0004197_abnormal_fetal_growth/weight/ | 1.06356034 |
| 91 | MP0002084_abnormal_developmental_patter | 1.04123005 |
| 92 | MP0003221_abnormal_cardiomyocyte_apopto | 1.00266852 |
| 93 | MP0009785_altered_susceptibility_to | 0.99737803 |
| 94 | MP0003075_altered_response_to | 0.98161057 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 0.96644206 |
| 96 | MP0000733_abnormal_muscle_development | 0.95858315 |
| 97 | MP0002085_abnormal_embryonic_tissue | 0.95737844 |
| 98 | MP0002419_abnormal_innate_immunity | 0.94960924 |
| 99 | MP0005409_darkened_coat_color | 0.93597809 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.92693315 |
| 101 | MP0001849_ear_inflammation | 0.92222362 |
| 102 | MP0003448_altered_tumor_morphology | 0.92159800 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.91577029 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.89942183 |
| 105 | MP0001853_heart_inflammation | 0.86895999 |
| 106 | MP0005023_abnormal_wound_healing | 0.85443480 |
| 107 | MP0004185_abnormal_adipocyte_glucose | 0.85218309 |
| 108 | MP0009764_decreased_sensitivity_to | 0.85088581 |
| 109 | MP0004264_abnormal_extraembryonic_tissu | 0.84766489 |
| 110 | MP0001915_intracranial_hemorrhage | 0.84272238 |
| 111 | MP0005621_abnormal_cell_physiology | 0.84043844 |
| 112 | MP0000371_diluted_coat_color | 0.83520627 |
| 113 | MP0003191_abnormal_cellular_cholesterol | 0.81935780 |
| 114 | MP0003329_amyloid_beta_deposits | 0.81431685 |
| 115 | MP0008469_abnormal_protein_level | 0.76990217 |
| 116 | MP0006054_spinal_hemorrhage | 0.76495839 |
| 117 | MP0010234_abnormal_vibrissa_follicle | 0.75973360 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.75080255 |
| 119 | MP0002925_abnormal_cardiovascular_devel | 0.74800692 |
| 120 | MP0001663_abnormal_digestive_system | 0.73739795 |
| 121 | MP0009672_abnormal_birth_weight | 0.73661004 |
| 122 | MP0003091_abnormal_cell_migration | 0.73581511 |
| 123 | MP0005390_skeleton_phenotype | 0.73520308 |
| 124 | MP0004233_abnormal_muscle_weight | 0.73172004 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.69867659 |
| 126 | MP0005384_cellular_phenotype | 0.69515209 |
| 127 | MP0008932_abnormal_embryonic_tissue | 0.68807752 |
| 128 | MP0010630_abnormal_cardiac_muscle | 0.67756383 |
| 129 | MP0008874_decreased_physiological_sensi | 0.65987037 |
| 130 | MP0008004_abnormal_stomach_pH | 0.65646470 |
| 131 | MP0002933_joint_inflammation | 0.63899449 |
| 132 | MP0004381_abnormal_hair_follicle | 0.63853931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 3.65386130 |
| 2 | Hyperacusis (HP:0010780) | 3.22679835 |
| 3 | T lymphocytopenia (HP:0005403) | 3.05239051 |
| 4 | Orchitis (HP:0100796) | 2.96364314 |
| 5 | Abnormality of T cell number (HP:0011839) | 2.94643920 |
| 6 | Recurrent viral infections (HP:0004429) | 2.90723872 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 2.89161883 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 2.86834114 |
| 9 | Optic neuritis (HP:0100653) | 2.86834114 |
| 10 | Ependymoma (HP:0002888) | 2.84354080 |
| 11 | Heterotopia (HP:0002282) | 2.82891394 |
| 12 | Increased density of long bones (HP:0006392) | 2.79429092 |
| 13 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.78808381 |
| 14 | Abnormality of macrophages (HP:0004311) | 2.77512734 |
| 15 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.76440732 |
| 16 | Obstructive sleep apnea (HP:0002870) | 2.75528209 |
| 17 | Increased nuchal translucency (HP:0010880) | 2.73006627 |
| 18 | Nasal polyposis (HP:0100582) | 2.69792845 |
| 19 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.57056532 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.55262837 |
| 21 | Abnormality of T cells (HP:0002843) | 2.54595794 |
| 22 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.53990361 |
| 23 | Short 4th metacarpal (HP:0010044) | 2.53990361 |
| 24 | Thrombocytosis (HP:0001894) | 2.49956905 |
| 25 | Gastrointestinal stroma tumor (HP:0100723) | 2.48262851 |
| 26 | Basal cell carcinoma (HP:0002671) | 2.43326501 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 2.42863593 |
| 28 | Papilloma (HP:0012740) | 2.42054797 |
| 29 | Verrucae (HP:0200043) | 2.42054797 |
| 30 | Chronic otitis media (HP:0000389) | 2.41801110 |
| 31 | Bicuspid aortic valve (HP:0001647) | 2.38917483 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 2.34418076 |
| 33 | Gastrointestinal inflammation (HP:0004386) | 2.32955910 |
| 34 | Emphysema (HP:0002097) | 2.32453547 |
| 35 | Gingivitis (HP:0000230) | 2.30692702 |
| 36 | Meningitis (HP:0001287) | 2.29963017 |
| 37 | Cutis marmorata (HP:0000965) | 2.29917833 |
| 38 | Vasculitis (HP:0002633) | 2.29418498 |
| 39 | Sparse lateral eyebrow (HP:0005338) | 2.28149368 |
| 40 | Keratoconjunctivitis sicca (HP:0001097) | 2.19871220 |
| 41 | Fatigue (HP:0012378) | 2.19847070 |
| 42 | Insomnia (HP:0100785) | 2.18410300 |
| 43 | Astrocytoma (HP:0009592) | 2.17227027 |
| 44 | Abnormality of the astrocytes (HP:0100707) | 2.17227027 |
| 45 | Autoimmune thrombocytopenia (HP:0001973) | 2.14856903 |
| 46 | Trigonocephaly (HP:0000243) | 2.14074640 |
| 47 | Elfin facies (HP:0004428) | 2.13476372 |
| 48 | Slow saccadic eye movements (HP:0000514) | 2.13046868 |
| 49 | Prominent nose (HP:0000448) | 2.12387367 |
| 50 | Volvulus (HP:0002580) | 2.10308423 |
| 51 | Onion bulb formation (HP:0003383) | 2.10127094 |
| 52 | Recurrent bronchitis (HP:0002837) | 2.09997642 |
| 53 | Disproportionate tall stature (HP:0001519) | 2.09770283 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.06497343 |
| 55 | Inflammation of the large intestine (HP:0002037) | 2.05984021 |
| 56 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.05852973 |
| 57 | Obstructive lung disease (HP:0006536) | 2.03235301 |
| 58 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03235301 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.02878241 |
| 60 | Anal stenosis (HP:0002025) | 2.02524012 |
| 61 | Abnormality of the anterior horn cell (HP:0006802) | 2.01843697 |
| 62 | Degeneration of anterior horn cells (HP:0002398) | 2.01843697 |
| 63 | Long eyelashes (HP:0000527) | 2.01185290 |
| 64 | Malignant gastrointestinal tract tumors (HP:0006749) | 1.99187222 |
| 65 | Gastrointestinal carcinoma (HP:0002672) | 1.99187222 |
| 66 | Amaurosis fugax (HP:0100576) | 1.98807622 |
| 67 | Deviation of the thumb (HP:0009603) | 1.98793509 |
| 68 | Chest pain (HP:0100749) | 1.98358579 |
| 69 | Abnormality of T cell physiology (HP:0011840) | 1.98275911 |
| 70 | Cellulitis (HP:0100658) | 1.97671185 |
| 71 | Broad face (HP:0000283) | 1.97631787 |
| 72 | Proximal placement of thumb (HP:0009623) | 1.97337679 |
| 73 | Hemorrhage of the eye (HP:0011885) | 1.96619609 |
| 74 | Posterior subcapsular cataract (HP:0007787) | 1.96606650 |
| 75 | Peripheral hypomyelination (HP:0007182) | 1.96385611 |
| 76 | Colitis (HP:0002583) | 1.95778501 |
| 77 | Cerebral aneurysm (HP:0004944) | 1.94804544 |
| 78 | Metaphyseal cupping (HP:0003021) | 1.93604308 |
| 79 | IgM deficiency (HP:0002850) | 1.93343512 |
| 80 | Interstitial pulmonary disease (HP:0006530) | 1.92061897 |
| 81 | High pitched voice (HP:0001620) | 1.91454167 |
| 82 | Spontaneous hematomas (HP:0007420) | 1.90944191 |
| 83 | Abnormality of the columella (HP:0009929) | 1.90885075 |
| 84 | Long palpebral fissure (HP:0000637) | 1.90737092 |
| 85 | Subacute progressive viral hepatitis (HP:0006572) | 1.90601667 |
| 86 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.89977576 |
| 87 | Keratoconjunctivitis (HP:0001096) | 1.89562123 |
| 88 | Cortical dysplasia (HP:0002539) | 1.89561689 |
| 89 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.87837030 |
| 90 | Congenital stationary night blindness (HP:0007642) | 1.87254747 |
| 91 | Annular pancreas (HP:0001734) | 1.86113294 |
| 92 | Cafe-au-lait spot (HP:0000957) | 1.86039790 |
| 93 | Deep palmar crease (HP:0006191) | 1.84769986 |
| 94 | Aortic aneurysm (HP:0004942) | 1.84727081 |
| 95 | Combined immunodeficiency (HP:0005387) | 1.84520321 |
| 96 | Viral hepatitis (HP:0006562) | 1.84502748 |
| 97 | Germ cell neoplasia (HP:0100728) | 1.84332972 |
| 98 | Recurrent skin infections (HP:0001581) | 1.84323368 |
| 99 | Hand muscle atrophy (HP:0009130) | 1.84277327 |
| 100 | Skin tags (HP:0010609) | 1.82932746 |
| 101 | Pointed chin (HP:0000307) | 1.82456878 |
| 102 | Urticaria (HP:0001025) | 1.81788205 |
| 103 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.81250497 |
| 104 | Osteomyelitis (HP:0002754) | 1.81183647 |
| 105 | Lymphopenia (HP:0001888) | 1.81095425 |
| 106 | Reticulocytosis (HP:0001923) | 1.80831717 |
| 107 | Medulloblastoma (HP:0002885) | 1.79477706 |
| 108 | Leiomyosarcoma (HP:0100243) | 1.78837898 |
| 109 | Uterine leiomyosarcoma (HP:0002891) | 1.78837898 |
| 110 | Arterial thrombosis (HP:0004420) | 1.78204205 |
| 111 | Myositis (HP:0100614) | 1.78019697 |
| 112 | Adenoma sebaceum (HP:0009720) | 1.78000783 |
| 113 | Angiofibromas (HP:0010615) | 1.78000783 |
| 114 | Dislocated radial head (HP:0003083) | 1.77505500 |
| 115 | Polygenic inheritance (HP:0010982) | 1.77164013 |
| 116 | Thoracic kyphosis (HP:0002942) | 1.77008010 |
| 117 | Renal duplication (HP:0000075) | 1.76198755 |
| 118 | Increased IgE level (HP:0003212) | 1.75842998 |
| 119 | Abnormality of the thoracic spine (HP:0100711) | 1.74939010 |
| 120 | Bowel incontinence (HP:0002607) | 1.74736457 |
| 121 | Abnormality of the 4th metacarpal (HP:0010012) | 1.74735827 |
| 122 | Dysmetric saccades (HP:0000641) | 1.74388534 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 1.73632639 |
| 124 | Intestinal fistula (HP:0100819) | 1.73164277 |
| 125 | Abnormality of the intervertebral disk (HP:0005108) | 1.72277407 |
| 126 | Macroorchidism (HP:0000053) | 1.71635233 |
| 127 | Abnormal number of incisors (HP:0011064) | 1.71411739 |
| 128 | Recurrent cutaneous fungal infections (HP:0011370) | 1.70822892 |
| 129 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.70822892 |
| 130 | Broad palm (HP:0001169) | 1.70558308 |
| 131 | Lip pit (HP:0100267) | 1.70417859 |
| 132 | Mediastinal lymphadenopathy (HP:0100721) | 1.70301385 |
| 133 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.69713240 |
| 134 | Hypertensive crisis (HP:0100735) | 1.69272031 |
| 135 | Decreased motor nerve conduction velocity (HP:0003431) | 1.69087796 |
| 136 | Ureteral stenosis (HP:0000071) | 1.66504283 |
| 137 | Recurrent abscess formation (HP:0002722) | 1.65996747 |
| 138 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.65685105 |
| 139 | Abnormality of reticulocytes (HP:0004312) | 1.65543737 |
| 140 | Abnormal large intestine physiology (HP:0012700) | 1.65453784 |
| 141 | Spinal muscular atrophy (HP:0007269) | 1.65181938 |
| 142 | Selective tooth agenesis (HP:0001592) | 1.64589409 |
| 143 | Myelodysplasia (HP:0002863) | 1.64351287 |
| 144 | Poikilocytosis (HP:0004447) | 1.64245890 |
| 145 | Polycythemia (HP:0001901) | 1.64185477 |
| 146 | Abnormality of the radial head (HP:0003995) | 1.64067907 |
| 147 | Persistence of primary teeth (HP:0006335) | 1.64049391 |
| 148 | Restrictive lung disease (HP:0002091) | 1.63850658 |
| 149 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.63725593 |
| 150 | Renovascular hypertension (HP:0100817) | 1.63501056 |
| 151 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.63409785 |
| 152 | Skull defect (HP:0001362) | 1.62577783 |
| 153 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.62565929 |
| 154 | Increased IgM level (HP:0003496) | 1.61491974 |
| 155 | Pustule (HP:0200039) | 1.60914364 |
| 156 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.60826389 |
| 157 | Hypochromic anemia (HP:0001931) | 1.60627886 |
| 158 | Prolonged bleeding time (HP:0003010) | 1.60305948 |
| 159 | Pulmonary infiltrates (HP:0002113) | 1.58961343 |
| 160 | Ulnar bowing (HP:0003031) | 1.58723119 |
| 161 | Mask-like facies (HP:0000298) | 1.58501694 |
| 162 | Narrow palate (HP:0000189) | 1.58368214 |
| 163 | Encephalitis (HP:0002383) | 1.58130549 |
| 164 | Pelvic girdle muscle weakness (HP:0003749) | 1.58070585 |
| 165 | Agammaglobulinemia (HP:0004432) | 1.57742922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 4.28293920 |
| 2 | EEF2K | 4.14488562 |
| 3 | MAP3K10 | 3.83786536 |
| 4 | TRIB3 | 3.46843578 |
| 5 | PKN2 | 3.21418491 |
| 6 | MAP4K1 | 3.06007247 |
| 7 | CDK12 | 2.87809323 |
| 8 | RIPK4 | 2.79885938 |
| 9 | SMG1 | 2.63631135 |
| 10 | BUB1 | 2.46036109 |
| 11 | NEK2 | 2.20527771 |
| 12 | CDC7 | 2.19945526 |
| 13 | STK10 | 2.01960415 |
| 14 | PASK | 1.93479578 |
| 15 | JAK3 | 1.87597544 |
| 16 | FGFR3 | 1.86619129 |
| 17 | GRK6 | 1.79061580 |
| 18 | TYK2 | 1.76579861 |
| 19 | IRAK3 | 1.61317861 |
| 20 | MAP3K3 | 1.60343980 |
| 21 | RPS6KA4 | 1.45878160 |
| 22 | ERN1 | 1.44147570 |
| 23 | STK24 | 1.43698639 |
| 24 | PTK6 | 1.41632086 |
| 25 | MARK2 | 1.41443808 |
| 26 | CDK4 | 1.39550480 |
| 27 | BLK | 1.38664127 |
| 28 | FGFR4 | 1.38527890 |
| 29 | FLT3 | 1.38097882 |
| 30 | SCYL2 | 1.37328849 |
| 31 | NEK1 | 1.36790236 |
| 32 | EPHB1 | 1.34949030 |
| 33 | TTN | 1.33023782 |
| 34 | LRRK2 | 1.31596309 |
| 35 | ZAP70 | 1.30811120 |
| 36 | ITK | 1.24853497 |
| 37 | BTK | 1.24798161 |
| 38 | CDC42BPA | 1.21486133 |
| 39 | KSR2 | 1.18487240 |
| 40 | ALK | 1.16409157 |
| 41 | BRD4 | 1.15291277 |
| 42 | FES | 1.11730907 |
| 43 | CHUK | 1.11119031 |
| 44 | MAP3K8 | 1.09476381 |
| 45 | RIPK1 | 1.09242504 |
| 46 | CAMK1D | 1.08255590 |
| 47 | MAP2K3 | 1.08156822 |
| 48 | STK4 | 1.07660526 |
| 49 | JAK1 | 1.06764309 |
| 50 | PIM1 | 1.04145544 |
| 51 | ATR | 1.01167810 |
| 52 | TBK1 | 1.00896578 |
| 53 | RPS6KB2 | 0.98238491 |
| 54 | DYRK3 | 0.94619472 |
| 55 | TAOK1 | 0.94335054 |
| 56 | MAP3K1 | 0.92964288 |
| 57 | MATK | 0.92514466 |
| 58 | MAP3K7 | 0.91837231 |
| 59 | SIK3 | 0.90410700 |
| 60 | SIK2 | 0.90301685 |
| 61 | IRAK2 | 0.87969776 |
| 62 | ICK | 0.87634978 |
| 63 | MTOR | 0.86849132 |
| 64 | PAK4 | 0.85329757 |
| 65 | EPHA3 | 0.84511030 |
| 66 | IRAK1 | 0.83907017 |
| 67 | TESK2 | 0.82953639 |
| 68 | TXK | 0.82010642 |
| 69 | FGR | 0.81374062 |
| 70 | CSK | 0.80058235 |
| 71 | FGFR1 | 0.79573365 |
| 72 | IKBKE | 0.79278557 |
| 73 | SYK | 0.79212078 |
| 74 | MAP3K6 | 0.78478678 |
| 75 | TGFBR1 | 0.78267193 |
| 76 | WNK1 | 0.77681412 |
| 77 | PDGFRA | 0.77516335 |
| 78 | MELK | 0.77503086 |
| 79 | CDK9 | 0.76719039 |
| 80 | IKBKB | 0.76204135 |
| 81 | CHEK1 | 0.75272103 |
| 82 | MAP3K14 | 0.75085691 |
| 83 | HIPK2 | 0.74838649 |
| 84 | HCK | 0.74773052 |
| 85 | JAK2 | 0.73852863 |
| 86 | ACVR1B | 0.71062501 |
| 87 | MAPK7 | 0.69412508 |
| 88 | TNK2 | 0.68820607 |
| 89 | MAP3K2 | 0.68690798 |
| 90 | SGK3 | 0.68530000 |
| 91 | CDK6 | 0.68262019 |
| 92 | MAPK12 | 0.66980982 |
| 93 | CAMK4 | 0.65561324 |
| 94 | PRKD2 | 0.64446734 |
| 95 | CLK1 | 0.63739725 |
| 96 | CAMK1G | 0.62546412 |
| 97 | SIK1 | 0.62139516 |
| 98 | RPS6KA1 | 0.62007939 |
| 99 | BMX | 0.61674165 |
| 100 | MAP3K11 | 0.60872827 |
| 101 | PDPK1 | 0.58951346 |
| 102 | TSSK6 | 0.57855549 |
| 103 | YES1 | 0.57646311 |
| 104 | CDK7 | 0.57198277 |
| 105 | MAPK11 | 0.56610302 |
| 106 | LCK | 0.56412669 |
| 107 | LYN | 0.56079127 |
| 108 | CSF1R | 0.55806221 |
| 109 | DMPK | 0.55395999 |
| 110 | BRSK1 | 0.54638339 |
| 111 | CDK2 | 0.53967351 |
| 112 | PDK1 | 0.53823390 |
| 113 | RET | 0.53783792 |
| 114 | AURKB | 0.53351627 |
| 115 | RPS6KA2 | 0.50691168 |
| 116 | WEE1 | 0.49718546 |
| 117 | IRAK4 | 0.48261781 |
| 118 | TYRO3 | 0.47869637 |
| 119 | MAP2K2 | 0.46567783 |
| 120 | TAOK3 | 0.45432803 |
| 121 | TTK | 0.45278148 |
| 122 | TGFBR2 | 0.45169824 |
| 123 | TLK1 | 0.45101490 |
| 124 | MAPKAPK3 | 0.45074095 |
| 125 | CAMKK1 | 0.44983734 |
| 126 | RPS6KA6 | 0.44185465 |
| 127 | ATM | 0.43867025 |
| 128 | PLK1 | 0.43346811 |
| 129 | MAP3K13 | 0.43104281 |
| 130 | DYRK1B | 0.42951039 |
| 131 | SGK2 | 0.42375299 |
| 132 | PDGFRB | 0.42323256 |
| 133 | SGK494 | 0.42227209 |
| 134 | SGK223 | 0.42227209 |
| 135 | CHEK2 | 0.39688648 |
| 136 | RPS6KC1 | 0.39658596 |
| 137 | RPS6KL1 | 0.39658596 |
| 138 | MAPKAPK2 | 0.38748054 |
| 139 | TAOK2 | 0.37384134 |
| 140 | NTRK2 | 0.34922158 |
| 141 | MAP3K5 | 0.34472860 |
| 142 | KIT | 0.33291878 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 2.73055781 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.22569073 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.05062078 |
| 4 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.04302119 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 1.88181827 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 1.78851175 |
| 7 | Cell cycle_Homo sapiens_hsa04110 | 1.74333704 |
| 8 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74095056 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.70729060 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66974422 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 1.62800223 |
| 12 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.57599708 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57443618 |
| 14 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.55462542 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.54531018 |
| 16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49859573 |
| 17 | HTLV-I infection_Homo sapiens_hsa05166 | 1.46615899 |
| 18 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.45734455 |
| 19 | Hepatitis C_Homo sapiens_hsa05160 | 1.43277393 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.42999639 |
| 21 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.41875774 |
| 22 | Apoptosis_Homo sapiens_hsa04210 | 1.40312759 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39246101 |
| 24 | RNA transport_Homo sapiens_hsa03013 | 1.37901266 |
| 25 | Colorectal cancer_Homo sapiens_hsa05210 | 1.37200018 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.37154953 |
| 27 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.36276083 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34981721 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.34094962 |
| 30 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.33765871 |
| 31 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.32087430 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.32051740 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31306047 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30314134 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.29535918 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.26416021 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22011140 |
| 38 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.21740325 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.19250065 |
| 40 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.18830329 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.18125794 |
| 42 | Malaria_Homo sapiens_hsa05144 | 1.18011360 |
| 43 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14357819 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.13560775 |
| 45 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.11586553 |
| 46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.07490153 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07484873 |
| 48 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.06256890 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.05615310 |
| 50 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.05527757 |
| 51 | Endometrial cancer_Homo sapiens_hsa05213 | 1.04034086 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 1.03684754 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.03356433 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 1.02752226 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 1.00897355 |
| 56 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00422439 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.00034468 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.99650193 |
| 59 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.98745500 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98323413 |
| 61 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96359532 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96190633 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.94469687 |
| 64 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94248587 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.92478135 |
| 66 | Lysine degradation_Homo sapiens_hsa00310 | 0.92059414 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90888263 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90544102 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.89905487 |
| 70 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89187991 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.88596146 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88308500 |
| 73 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88023712 |
| 74 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.87774860 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.87682248 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87304840 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84316350 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.83630375 |
| 79 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82687620 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.82512709 |
| 81 | Glioma_Homo sapiens_hsa05214 | 0.81749915 |
| 82 | Pertussis_Homo sapiens_hsa05133 | 0.80174183 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.79967426 |
| 84 | RNA degradation_Homo sapiens_hsa03018 | 0.79262340 |
| 85 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78721094 |
| 86 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77546773 |
| 87 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.77185089 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.76748568 |
| 89 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76713172 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76129991 |
| 91 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76074123 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.74980929 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73023493 |
| 94 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.72739267 |
| 95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69705584 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | 0.68082881 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.67986872 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67331647 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.67194534 |
| 100 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66561763 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66046685 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65848689 |
| 103 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65760825 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62688279 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.62548593 |
| 106 | Endocytosis_Homo sapiens_hsa04144 | 0.62149459 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.61510055 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.61441924 |
| 109 | Pathways in cancer_Homo sapiens_hsa05200 | 0.59885563 |
| 110 | Homologous recombination_Homo sapiens_hsa03440 | 0.59534421 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57565955 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57558784 |
| 113 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.57471142 |
| 114 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57060936 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.56981797 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56032389 |
| 117 | Tuberculosis_Homo sapiens_hsa05152 | 0.54772276 |
| 118 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53978648 |
| 119 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53892403 |
| 120 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.52650467 |
| 121 | Long-term potentiation_Homo sapiens_hsa04720 | 0.52594336 |
| 122 | Prostate cancer_Homo sapiens_hsa05215 | 0.52553855 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52316232 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52063619 |
| 125 | Allograft rejection_Homo sapiens_hsa05330 | 0.51581531 |
| 126 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51323245 |
| 127 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.51114561 |
| 128 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47285816 |

